According to Enanta Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is โน5.76 Billion. a decrease over the revenue in the year 2023 that were of โน6.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน5.71 B | -6.79% |
2023 | โน6.12 B | -9.78% |
2022 | โน6.79 B | -1.84% |
2021 | โน6.92 B | -6.9% |
2020 | โน7.43 B | -44.52% |
2019 | โน13.39 B | -19.63% |
2018 | โน16.66 B | 100.05% |
2017 | โน8.33 B | 144.08% |
2016 | โน3.41 B | -61.03% |
2015 | โน8.76 B | 11.16% |
2014 | โน7.88 B | 2407.61% |
2013 | โน0.31 B | -91.66% |
2012 | โน3.76 B |